Form 4: NeuroOne Medical Technologies Executive Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
Mark Christianson, Business Development Director at NeuroOne Medical Technologies, disposed of 90 shares of common stock on May 31, 2024, to cover tax obligations.
Summary
- On May 31, 2024, Mark Christianson, the Business Development Director of NeuroOne Medical Technologies Corp, disposed of 90 shares of common stock.
- The transaction was executed at a price of $0.9299 per share.
- This disposal was related to covering tax obligations.
- Following the transaction, Christianson directly owns 323,024 shares of NeuroOne Medical Technologies Corp.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This transaction is a common occurrence where executives sell shares to cover tax obligations.
Stakeholder Impact
- The disposal of a small number of shares is unlikely to have a significant impact on shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/31/2024 | Date of transaction: Disposal of 90 shares of common stock. |
| 06/04/2024 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.